Application of the Latest Therapeutic Strategies to Treat Acute Lymphoblastic Leukemia

Review the latest data and expert recommendations on incorporating emerging therapeutic strategies into the care of patients with ALL. This comprehensive program includes an Interactive Decision Support Tool, expert commentaries, and an expert-authored module with downloadable slideset.
Daniel J. DeAngelo, MD, PhD
Amir Fathi, MD
Elias Jabbour, MD
person default
Aaron C. Logan, MD, PhD
Jae H. Park, MD
Eunice S. Wang, MD


Amir T. Fathi, MD, reviews patient cases and the most recent clinical data to provide guidance on optimizing care for acute lymphoblastic leukemia using newer immunotherapy approaches.

Amir Fathi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 16, 2020 Expired: April 15, 2021


Here’s my take on important considerations for ALL diagnosis and initial workup that inform treatment decisions.

Daniel J. DeAngelo, MD, PhD Released: October 16, 2019

Gain expert clinical insights from Jae H. Park, MD, on the anticipation, preparation, and management of toxicities associated with immunotherapies used for patients with ALL.

Jae H. Park, MD Released: December 17, 2019

How do you manage patients with ALL in the era of immunotherapy? In this commentary, Eunice S. Wang, MD, discusses a novel approach of combining chemotherapy with immunotherapy to treat patients with ALL.

Eunice S. Wang, MD Released: February 25, 2020

Are you interested in seeing treatment recommendations for adult patients with B-cell ALL from 5 experts? In this commentary, Jae H. Park, MD, describes an online Interactive Decision Support Tool that provides expert guidance to clinicians on treatment options for adult patients with B-cell ALL.

Jae H. Park, MD Released: May 15, 2020

Downloadable Slideset

Download these slides to review expert insights on optimizing treatment for patients with ALL.

Amir Fathi, MD Released: April 16, 2020

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with ALL with those of 5 renowned experts.

Daniel J. DeAngelo, MD, PhD Elias Jabbour, MD person default Aaron C. Logan, MD, PhD Jae H. Park, MD Eunice S. Wang, MD Released: April 21, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Jazz Pharmaceuticals, Inc.
Pfizer Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?